Authors: B Hedon¹; JN Hugues²; JC Emperaire³; JJ Chabaud⁴; D Barbereau⁵; A Boujenah⁶; CM Howles⁷; F Truong⁸

Source: Human Reproduction, Volume 13, Number 10, October 1998 , pp. 2688-2692(5)

Publisher: Oxford University Press

Abstract:

The efficacy and safety of a chronic low dose (group A) and a conventional (group B) stimulation regimen of recombinant human follicle stimulating hormone (r-HFSH) were compared in 103 WHO Group II infertile women with clomiphene citrate-resistant anovulation. Mono- or bifollicular development was induced in 88.1% of patients in group A compared with 76.1% in group B. Ovulation and pregnancy rates were higher in group A (71.4% and 33.3%, respectively) than in group B (63.0% and 20%), but these differences were not statistically significant. Additionally, the total number of follicles that were >10 mm diameter was lower in group A than group B (3.0 ± 2.6 versus 6.3 ± 6.5; P < 0.0001), as was the oestradiol concentration (504 ± 477 pg/ml versus 988 ± 740 pg/ml; P < 0.03). The median dose of FSH (75 IU ampoules) used per cycle was 11 ampoules in group A and 12.5 in group B. In terms of the incidence of ovarian hyperstimulation syndrome, no differences were recorded between the two groups. The results demonstrated that r-HFSH is effective and safe in both these treatment protocols. The chronic low dose regimen was associated with a trend towards a higher rate of mono- or bifollicular development, without jeopardizing the incidence of pregnancy.

Keywords:anovulation/induction of ovulation/low-dose/r-HFSH

Document Type: Research article

Affiliations: 1: Arnaud de Villeneuve University Hospital, F-34259 Montpellier Cedex 5, France 2: Jean Verdier Hospital, F-93140 Bondy, France 3: Private Institute, F-33000 Bordeaux, France 4: Clinique Pasteur Saint Esprit, F-29200 Brest, France 5: Rhonalpin Institute, F-69500 Bron, France 6: Muette Clinic, F-75016 Paris, France 7: Ares-Serono, Geneva, Switzerland 8: Laboratories Serono, France

Publication date: 1998-10-01

More about this publication?

• Human Reproduction features full-length, peer-reviewed papers reporting original research, clinical case histories, as well as opinions and debates on topical issues. Papers published cover the scientific and medical aspects of reproductive physiology and pathology, endocrinology, andrology, gonad function, gametogenesis, fertilization, embryo development, implantation, pregnancy, genetics, genetic diagnosis, oncology, infectious disease, surgery, contraception, infertility treatment, psychology, ethics and social issues. The highest scientific and editorial standard is maintained throughout the journal along with a rapid rate of publication.

Related content

• In this: publication
• By this: publisher
• In this Subject: Anatomy & Physiology ,  Obstetrics & Gynecology
• By this author: B Hedon ;  JN Hugues ;  JC Emperaire ;  JJ Chabaud ;  D Barbereau ;  A Boujenah ;  CM Howles ;  F Truong

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers